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Close to 14% of the global burden of disease can be attributed to 
neuropsychiatric disorders primarily related to the disabling nature 
of common mental disorders (CMDs),[1,2] which typically include 
depression, anxiety and psychoactive substance use or alcohol use 
disorder. A review and meta-analysis of studies between 1980 and 
2013 established that 29.2% of individuals globally experienced 
CMDs at some point in their lifetime.[3] CMDs have been shown 
to contribute to the burden of disease in low- and middle-income 
countries,[4-6] and can variously compromise adherence to treatment, 
health behaviour change and self-management efforts.[7-9] In South 
Africa (SA), almost a third (30.3%) of the population has experienced 
a CMD in their lifetime,[10] with a 12-month prevalence estimate of 
16.5% for CMDs (anxiety, mood and substance use disorders).[11] 
Although effective treatment for mental disorders is available[12,13] 
and can be delivered in routine primary healthcare (PHC),[14] only 
about half of patients with a depressive disorder in high-income 
settings are detected[15,16] and only 16.5% of all individuals with a 
12-month major depressive disorder receive minimally adequate 
treatment.[17] In SA this gap is far greater, with only one in four people 
with a CMD reporting receiving treatment of any kind.[18] While 
integrating mental healthcare into existing health systems may be 
the most effective and cost-efficient approach to improve access to 
mental health services in SA, it requires addressing major knowledge 
gaps, inter alia the development and assessment of interventions that 
integrate mental health screening and treatment into existing health 
systems[8,19] as well as training lay counsellors in the identification 
of mental disorders.[20] However, screening that is integrated into 
routine care must use measures that can be administered by non-
specialist health staff, are brief and easy to administer, and promote 
high specificity given the meagre resources available to treat false 
positives.[21]
Objectives
This validation study was a substudy of the Southern African Mental 
Health Integration project on evaluating the scale-up of evidence-
based packages for integration of mental healthcare in PHC settings 
for depression and alcohol use disorders into routine care that is part 
of the Mental Health Integration Programme (MhINT). Continuous 
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Background. Integrating care for common mental disorders (CMDs) such as depression, anxiety and alcohol abuse into primary healthcare 
(PHC) should assist in reducing South Africa (SA)’s quadruple burden of disease. CMDs compromise treatment adherence, health 
behaviour change and self-management of illnesses. Appropriate identification of mental disorders in primary care can be facilitated by 
brief, easy-to-administer screening that promotes high specificity.
Objectives. To establish the criterion-based validity of a seven-item Brief Mental Health (BMH) screening tool for assessing positive 
symptoms of CMDs in primary care patients.
Methods. A total of 1 214 participants were recruited from all patients aged ≥18 years visiting 10 clinics as part of routine care in the 
Newcastle subdistrict of Amajuba District in KwaZulu-Natal Province, SA, over a period of 2 weeks. Consenting patients provided basic 
biographical information prior to screening with the BMH tool. PHC nurses remained blind to this assessment. PHC nurse-initiated 
assessment using the Adult Primary Care (APC) guidelines was the gold standard against which the performance of the BMH tool was 
compared. A specificity standard of 80% was used to establish cut-points. Specificity was favoured over sensitivity to ensure that those who 
did not have CMD symptoms were excluded, as well as to reduce over-referrals.
Results. Of the participants, 72% were female. The AUD-C (alcohol abuse) performed well (area under the curve (AUC) 0.91 (95% 
confidence interval (CI) 0.88 - 0.95), cut-point ≥4, Cronbach alpha 0.87); PHQ-2 (depression) performed reasonably well (AUC 0.72 (95% 
CI 0.65 - 0.78), cut-point ≥3, alpha 0.71); and GAD-2 (anxiety) performance was acceptable (AUC 0.69 (95% CI 0.58 - 0.80), cut-point ≥3, 
alpha 0.62). Using the higher cut-off scores, patients who truly did not have CMD symptoms had negative predictive values (NPVs) of >90%. 
Overall, 26% of patients had CMD positive symptoms relative to 8% using the APC guidelines.
Conclusions. Using a higher specificity index, the positive predictive value and NPV show that at higher cut-point values the BMH not only 
helps identify individuals with alcohol misuse, depression and anxiety symptoms but also identifies a majority of those who do not have 
symptoms (true negatives), thus not overburdening nurses with false positives needing assessment. Research is needed to assess whether 
use of such a short and valid screening tool is generalisable to other clinic contexts as well as how mental health screening should best be 
introduced into routine clinic functioning and practice.
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quality improvement strategies[22] that were 
being used to drive integration identified a 
lack of standardised screening tools as well 
as the complexity and non-implementation 
of existing tools as bottlenecks in identifying 
patients with CMDs.
The objective of the study was therefore 
to establish the criterion-based validity of 
a mental health screening tool for assessing 
positive symptoms of CMDs (depression, 
anxiety and substance abuse) among 
patients attending PHC facilities. The 
gold- standard criterion was nurse-initiated 
assess ment using the Adult Primary Care 
(APC) guidelines. This criterion was chosen 
given that the MhINT model, which is 
based on the collaborative care model of the 
Programme for Improving Mental Health 
Care (PRIME),[23] relies on professional 
nurses trained to use the APC for diagnosis 
of mental disorders. The APC is an 
integrated set of algorithmic guidelines that 
forms part of Integrated Clinical Systems 
Management.[24]
Methods
Setting
The study was conducted in the Newcastle 
subdistrict of the Amajuba District of 
KwaZulu-Natal Province, SA, over a period 
of 2 weeks. The Newcastle subdistrict, 
comprising both urban and rural areas and 
with a population of 389  117 in 2016,[25] is 
serviced by a district and provincial hospital 
and 14 PHC facilities. Of these, two clinics 
were excluded because they were linked 
to hospitals servicing the subdistrict and a 
third because its remote location made it 
difficult to conduct fieldwork.
Measures
The seven-item Brief Mental Health (BMH) 
screening tool comprises internationally 
validated tools: Alcohol Use Disorders 
Identification Test (AUD-C), Patient Health 
Questionnaire (PHQ-2) and Generalized 
Anxiety Disorder (GAD-2) measures (Fig. 1).
AUD-C
The AUD-C comprises the first three items 
of the 10-item AUDIT, which ask about 
frequency of drinking alcohol, number of 
alcoholic drinks and binge drinking. The 
AUD-C is recommended as a simple and 
reliable tool for routine assessment of risky 
drinking and screening for alcohol use 
disorders.[26,27] Internationally, a score ≥3 
for women or ≥4 for men is considered as 
screening positive for alcohol abuse. The 
AUDIT was previously validated for use in 
SA using trained nurses as a gold standard 
using the same cut-off points.[28]
PHQ-2
The PHQ-2 is a two-item self-report 
questionnaire in which participants are 
asked to rate how often they felt little interest 
or pleasure in doing things, and how often 
they felt down, depressed or hopeless over 
the past 2 weeks, as a screening measure 
for depression.[29,30] Original item responses 
of 0 - 3 (0 = not at all, 1 = several days, 2 = 
more than half the days, and 3 = nearly every 
day) were changed to 0 = not at all, 1 = 1 - 
7  days, 2 = 8 - 11 days, and 3 = 12 - 14 days), 
based on a previous criterion validity study 
of the PHQ-9 among SA PHC service users 
with chronic conditions.[31] A score of ≥2 
would be considered as screening positive 
for depression on the PHQ-2.
GAD-2
The scale comprising the first two items 
of the GAD-7 scale is recommended for 
screening for anxiety disorders in clinical 
practice, with further follow-up for those 
who screen positive.[32] A score of ≥3 is 
considered as screening positive for anxiety 
on the GAD-2. The GAD-2 has been used in 
screening for detecting antenatal depression 
and anxiety disorders in SA women[33] and is 
recommended for screening in primary care 
settings in the NICE guidelines.[34]
Criterion standard
The criterion standard for establishing the 
validity of screening tools would typically use 
another accepted standard of the construct 
under consideration, usually a clinician-
initiated diagnostic interview. As diagnostic 
assessments are done by the PHC nurse 
using the APC guidelines, each of the three 
scales was compared with an independent 
assessment done by a professional PHC 
nurse who had received advanced training in 
the use of the mental health APC guidelines.
Study procedures
Feasibility of the screening process was 
initially tested using enrolled nurses who 
randomly screened 10 patients in the ‘vitals 
screening room’ where all routine screening 
is done. An isiZulu version of the BMH was 
developed from the English version using 
standard translation and back-translation 
procedures. To enhance clarity, printed 
copies of the English and isiZulu versions 
of the BMH were used to compare meaning 
and wording changes, which resulted in the 
isiZulu translation for the word ‘depressed’ 
being changed from ‘unekhwantalala’ to 
‘unengcindezi’ and ‘anxious’ being changed 
from ‘unexhala’ to ‘unovalo’, as the substituted 
words were more commonly in use. No other 
changes were made to the BMH.
Following permission from the opera-
tional manager at each of the 10 clinic 
facilities, fieldworkers introduced the study 
to all the patients seated in the waiting area 
as an effort to help improve services. All 
patients consenting to participate in the 
Alcohol (Alcohol Use Disorders Identification Test AUD-C) 
1. How often have you had a drink containing alcohol in the last year? A “drink” can be a bottle of beer, a glass of wine, 
a wine cooler, or one cocktail or shot of hard liquor (like whiskey, gin, vodka). 
Never Monthly Two to four Two to three Four or more 
less times a month times per week times a week 
0 1 2 3 4 
2. How many drinks containing alcohol did you have on a typical day when you were drinking in the last year. 
Do not drink 1-2 drinks  3-4 drinks  5-6 drinks  7-9 drinks 10 or more 
0 0 1 2 3 4 
3. How often in the last year have you had 6 or more drinks on one occasion? 
Never Less than monthly Monthly Weekly Daily or almost daily 
0 1 2 3 4 
TOTAL SCORE (add the number for each question to get your total score)  
Scoring: A cut off score of ≥4 is screen positive 
Depression (The Patient Health Questionnaire PHQ-2) 
Over the past 2 weeks, how often have you been bothered by any of the following problems? 
Not at all 1-7 days 8-11 days 12-14 days 
1. Little interest or pleasure in doing things 0 1 2 3
2. Feeling down, depressed or hopeless 0 1 2 3
TOTAL SCORE (add the number for each question to get your total score)  
Scoring: A cut off score of ≥3 is screen positive 
Anxiety (Generalized Anxiety Disorder GAD-2) 
Over the past 2 weeks, how often have you been bothered by any of the following problems? 
Not at all 1-7 days 8-11 days 12-14 days 
0 1 2 31.      Feeling nervous, anxious, or on edge
2.      Not being able to stop or control worrying 0 1 2 3
TOTAL SCORE (add the number for each question to get your total score)  
Scoring: A cut off score of ≥3 is screen positive 
In all instances, screen positive means that the person has symptoms of the disorder and not necessarily the disorder itself. 
SCORE 
Fig. 1. Brief Mental Health screening tool.
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research were directed to a private room where they were told that the 
purpose of the research was to see whether symptoms of depression, 
anxiety and substance use could be identified using a checklist, prior 
to being asked the seven mental health screening questions (BMH) by 
the fieldworker. The patient’s information (date, clinic name, patient 
name and surname and identity number) was then entered onto a 
detachable pro forma sheet (professional nurse checklist).
The pro forma sheet reflecting the patient’s scores was detached 
and kept by the fieldworker for safekeeping and filing. A second 
part of the pro forma sheet with the patient information pre-filled 
by the fieldworker accompanied the patient to the PHC nurse, who 
assessed the patient using APC guidelines and entered the assessment 
in the patient’s file as well as on the pro forma (checklist). The PHC 
nurse remained blind to the patient’s scores on the BMH. After the 
consultation, the patient returned the completed checklist to the 
fieldworker to link the assessment made by the nurse with the mental 
health screening questions. All interviews were conducted in either 
English or isiZulu, depending on the language preference of the 
patient. On average, the entire process took 5 - 10 minutes without 
affecting patients’ waiting time.
Sample
Prevalence rates for CMDs vary depending on the study sample. 
The South African Stress and Health (SASH) community survey 
provided estimates ranging from 4.5% for alcohol abuse to 4.9% 
for major depression,[4] while clinic-based study populations reflect 
higher prevalence rates[35] and rates may be even higher among those 
with multimorbid chronic conditions.[36] Given these variations, 
the present study used the burden associated with neuropsychiatric 
disorders in sub-Saharan Africa of 10%,[37] with power of 80% and an 
overall significance level of 0.05, for a sample of 1 070 participants.[38]
All patients aged ≥18 years visiting the 10 clinics as part of routine 
care over a 2-week period were invited to participate in the study. 
Any patient in need of acute emergency treatment or unable to 
give written consent was excluded. Ninety-eight patients refused 
participation in the study and no further information is available on 
them; 1 214 participants were finally sampled.
Data analysis
While emphasis was placed on ensuring high specificity values[39] to 
establish cut-off scores to ensure that those who did not have CMD 
symptoms (true negatives) would be excluded and thereby also avoid 
overburdening the clinic with over-referrals, a solution reflecting 
optimal sensitivity values (>50%) in relation to high specificity values 
was favoured.
Descriptive statistics and internal consistency estimates were 
established for each of the subscales. The percentage correctly 
classified/likelihood ratio was determined on the basis of optimal 
cut-off values. The 10% prevalence rate used in this study was used 
to establish the positive predictive value (PPV) (the probability that 
people with CMD symptoms do have the condition of interest) and 
negative predictive value (NPV) (the probability that people without 
CMD symptoms do not have the condition). Receiver operating 
characteristics (ROC), the area under the curve (AUC) and the 95% 
confidence interval (CI) were calculated for each subscale. An ROC 
curve to determine the overall predictive value of the AUD-C, PHQ-2 
and GAD-2 against the criterion standard of the APC was calculated 
using Stata SE version 14.2 (StataCorp, USA).
Ethical considerations
Ethical approval was obtained from the University of KwaZulu-Natal 
Biomedical Research Ethics Committee (ref. no. BF190/17).
Results
Of the 1 214 adult patients sampled, 72% were female. This gender 
distribution is typical of PHC facilities in SA. No other details were 
collected from the sample, as the focus was on the validity of using 
the BMH in a real-world PHC setting.
AUD-C
ROC curve analysis showed that the AUD-C performed well, with an 
AUC of 0.91 (95% CI 0.88 - 0.95) (Fig. 2). A cut-point of ≥4 met the 
80% criteria of specificity, and the level of sensitivity was high at 82%. 
This cut-point correctly classified 82.5% of the population, and the 
likelihood ratio of a person testing positive for alcohol abuse was more 
than four times more likely (4.71) (Table 1, Fig. 2). The associated 
PPV/NPV values were 42.2% and 96.8%, respectively. The Cronbach 
alpha internal consistency estimate for the AUD-C was 0.87.
PHQ-2
The PHQ-2 performed moderately well, with an AUC of 0.72 (95% 
CI 0.65 - 0.78) (Table 2, Fig. 3). While a cut-point of ≥4 met the 
80% criteria of specificity, a cut-point of ≥3 was suggested as it also 
optimised sensitivity at 58%. At this cut-point, 76% of the population 
Table 1. Performance of the AUD-C in detecting alcohol use disorder among patients in routine care* (N=1 214)
Cut-point Sensitivity (%) Specificity (%) Correctly classified (%) LR+ LR–
≥0 100 0 1.41 1.00 0.00
≥1 100 67.62 68.08 3.09 0.00
≥2 100 71.15 71.56 3.47 0.00
≥3 100 76.20 76.53 4.20 0.00
≥4 82.35 82.51 82.50 4.71 0.21
≥5 64.71 88.14 87.81 5.46 0.40
≥6 58.82 91.93 91.46 7.29 0.45
≥7 41.18 94.62 93.86 7.65 0.62
≥8 35.29 96.55 95.69 10.23 0.67
≥9 29.41 97.98 97.01 14.57 0.72
≥10 17.65 98.82 97.68 14.99 0.83
≥11 11.76 99.50 98.26 23.31 0.89
≥12 5.88 99.92 98.59 69.95 0.94
>12 0 100 98.59 1.00 1.00
AUD-C = Alcohol Use Disorders Identification Test; LR+ = likelihood ratio positive; LR– = likelihood ratio negative.
*Adult Primary Care assessment by the primary healthcare nurse was used as a diagnostic reference standard.
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was correctly classified and the likelihood ratio of a person testing 
positive for depressive disorder was two and half times greater at this 
cut-point (2.56). The associated PPV/NPV values were 73.5% and 
92.9%, respectively. The Cronbach internal consistency estimate for 
the PHQ-2 was 0.71.
GAD-2
The GAD-2 AUC was 0.69 (95% CI 0.58 - 0.80) (Table 3, Fig. 4). A 
cut-point of ≥3 was suggested for the same reasons as the PHQ-2, 
resulting in a sensitivity of 59% and specificity of 76%. At this cut-
point, 75% of the population was correctly classified. The likelihood 
ratio of a person testing positive for anxiety disorder was just over 
two times greater at this cut-point (2.42). The associated PPV/NPV 
values were 89.8% and 93.5%, respectively. The Cronbach internal 
consistency estimate for the GAD-2 was 0.62.
Table 4 provides an overall summary of the relative cut-points, 
sensitivity, specificity and percentage correctly classified for each 
of the subscales. The PPV and NPV values indicate the likelihood 
of identifying patients who have the relevant symptoms against an 
optimised cut-point.
Discussion
The need for increased focus on CMDs as part of an integrated PHC 
service is important in the context of the shift in SA’s disease epidemic 
to multimorbid chronic conditions,[40] the high rate of comorbid 
CMDs, and the role that coexisting CMDs play in worsening 
treatment outcomes in patients with chronic conditions.[41] An 
important first step in reducing the treatment gap associated with 
low levels of identification of those in need of care at PHC level is the 
ability and capacity to identify CMDs.
Using a higher specificity index, a cut-off score of ≥4 identified 
alcohol use disorder (AUD-C) symptoms in 18% of patients, while 
a cut-off score of ≥3 on the PHQ-2 identified depressive symptoms 
in 24% and a cut-off score ≥3 on the GAD-2 identified anxiety 
symptoms in 25%. In comparison, APC assessment by PHC nurses 
showed that 17 patients (2%) had AUD and anxiety symptoms and 
57 (6%) had depression symptoms. Employing a higher specificity 
Table 2. Performance of the PHQ-2 in detecting depressive disorder among patients in routine care* (N=1 206)
Cut-point Sensitivity (%) Specificity (%) Correctly classified (%) LR+ LR–
≥0 100 0 4.73 1.00 0.00
≥1 92.98 26.28 29.44 1.26 0.27
≥2 78.95 49.26 50.66 1.56 0.43
≥3 57.89 77.37 76.45 2.56 0.54
≥4 42.11 86.86 84.74 3.20 0.67
≥5 17.54 93.56 89.97 2.72 0.88
≥6 12.28 95.74 91.79 2.88 0.92
>6 0 100 95.27 1.00 1.00
PHQ-2 = Patient Health Questionnaire; LR+ = likelihood ratio positive; LR– = likelihood ratio negative.
*Adult Primary Care assessment by the primary healthcare nurse was used as a diagnostic reference standard.
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Fig. 2. ROC curve for the AUD-C. (ROC = receiver operating characteristic; 
AUD-C = Alcohol Use Disorders Identification Test.)
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Fig. 4. ROC curve for the GAD-2. (ROC = receiver operating characteristic; 
GAD-2 = Generalized Anxiety Disorder measure.)
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standard and associated cut-offs, this validation study of the BMH 
found that between 18% and 25% of patients would need follow-up 
assessment for diagnosis.
Overall, 26% of patients were identified as having positive 
symptoms using the BMH screening tool, in contrast to 8% of 
patients using the APC guidelines. The high NPV values for each 
of the subscales of 96.8%, 92.9% and 93.5% for AUD-C, PHQ-2 and 
GAD-2, respectively, confirm that these cut-points will help rule out 
the probability of diagnosing patients who truly do not have CMD 
symptoms (Table 4).
In contrast, nurse identification of CMDs using the APC guidelines 
was low. They also made more dual diagnoses of disorders than 
individual diagnoses and had a high proportion of cases in which 
the diagnosis was indeterminate (7%) or missing (15%). It is possible 
that until recently PHC nurses did not routinely identify patients 
with CMDs since no clear referral pathways existed for treatment 
and follow-up. It is also likely that the APC guidelines may have been 
poorly trained or poorly applied; furthermore, use of an algorithm-
based diagnosis is more complex than a simple sum of scores 
(BMH). These findings are supported by international studies that 
indicate that training of PHC practitioners in identification of mental 
disorders does not necessarily improve identification for a number of 
reasons, including that: (i) visits are time-limited; (ii) the purpose of 
the PHC visit is generally for physical complaints; and (iii) psychiatric 
stigma may make it difficult for patients to talk about their emotional 
difficulties.[42]
However, the findings from several large-scale studies also 
indicate that when specific measures are used and little additional 
computation on the part of the clinician is required, the information 
from screening may be more readily integrated.[16] With screening 
having been found to improve diagnostic rates of mental disorders 
in PHC settings,[42] using the BMH in PHC settings should therefore 
assist PHC nurses in identifying specific patients for further 
assessment.
Study limitations
Limitations of this study include that we were unable to randomise 
patients given that the study occurred under real-world conditions, 
patients with conditions other than CMDs may have been missed or 
ignored, and the study was limited to one subdistrict in one region 
of the country.
Conclusions
In the context of low levels of treatment, the BMH screening tool with 
associated cut-offs favouring optimal sensitivity values (>50%) in 
relation to high specificity values is likely to minimise over-referrals. 
Used in this way, the BMH is likely to be useful for use in PHC 
settings to improve identification of CMDs and potentially increase 
the number of individuals receiving treatment. Further research 
is needed to assess whether use of the BMH does indeed improve 
identification of CMDs by PHC nurses through directing them to 
initiate assessment of patients for potential CMDs using the APC 
guidelines as well as to explore reasons for low levels of identification 
of CMDs when the BMH is not in use. There is a need to establish 
the generalisability of these findings through evaluation in various 
other facilities with appropriately powered samples. In addition, there 
is a need to assess how best to introduce mental health screening 
into routine clinic functioning and practice, as well as for further 
evaluation of the BMH when translated into different local languages 
and regions.
Table 3. Performance of the GAD-2 in detecting anxiety disorder among patients in routine care* (N=1 196)
Cut-point Sensitivity (%) Specificity (%) Correctly classified (%) LR+ LR–
≥0 100 0 1.42 1.00 0,00
≥1 88.24 35.03 35.79 1.36 0.34
≥2 82.35 56.74 57.11 1.90 0.31
≥3 58.82 75.66 75.42 2.42 0.54
≥4 11.76 87.11 86.04 0.91 1.01
≥5 0 94.49 93.14 0.00 1.06
≥6 0 96.10 94.73 0.00 1.04
>6 0 100 98.58 1.00 1.00
GAD-2 = Generalized Anxiety Disorder measure; LR+ = likelihood ratio positive; LR– = likelihood ratio negative.
*Adult Primary Care assessment by the primary healthcare nurse was used as a diagnostic reference standard.
Table 4. BMH cut-points, sensitivity and specificity, and PPV and NPV values
  Cut-point Sensitivity (%) Specificity (%) Correctly classified (%) n PPV (%) NPV (%)
AUD-C* (N=1 207) ≥4 82.35 82.51 82.50 222 42.2 96.8
  ≥5 64.71 88.07 87.74 152    
  ≥6 58.82 91.93 91.46 106    
PHQ-2† (N=1 207) ≥2 78.95 49.26 50.66 628    
  ≥3 57.89 77.37 76.45 293 73.5 92.9
  ≥4 42.11 86.86 84.74 175    
GAD-2† (N=1 197) ≥2 82.35 56.74 57.11 525    
  ≥3 58.82 75.66 75.42 297 89.8 93.5
  ≥4 11.76 87.11 86.04 154    
BMH = Brief Mental Health; PPV = positive predictive value; NPV = negative predictive value; AUD-C = Alcohol Use Disorders Identification Test; PHQ-2 = Patient Health Questionnaire; 
GAD-2 = Generalized Anxiety Disorder measure.
*International scale recommended cut-off: ≥3 for females and ≥4 for males. In this instance, one international cut-off was used: ≥4.
†International scale recommended cut-off: ≥2.
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